Host effects contributing to cancer therapy resistance

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• Tumor resistance to therapy remains a significant clinical challenge.
• Mechanisms of resistance include intrinsic tumor cell factors like efflux transporters and genetic alterations.
• The host's role in promoting therapy resistance is increasingly recognized.

Purpose of the Study:

• To review host-tumor interactions that contribute to therapy resistance.
• To emphasize the role of host cells and secreted factors in the tumor microenvironment.
• To explore therapeutic strategies targeting host responses.

Main Methods:

• Literature review focusing on host-tumor interactions in therapy resistance.
• Analysis of host cell recruitment and secreted factors in response to various cancer therapies.
• Synthesis of current understanding of the tumor microenvironment's role.

Main Results:

• Host cell recruitment to tumors post-therapy can protect cancer cells.
• Host responses can negate anti-tumor activity and promote a resistant phenotype.
• Specific host cells and secreted factors within the tumor microenvironment are key mediators.

Conclusions:

• Host-tumor interactions are critical determinants of therapy resistance.
• Targeting host responses offers a potential strategy to overcome resistance.
• Developing inhibitors of host response could improve cancer treatment efficacy and patient survival.